What antibiotics are effective for treating a urinary tract infection (UTI) caused by Enterococcus faecalis and Escherichia coli (E. coli) in a 92-year-old male with an indwelling catheter and potential impaired renal function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for UTI with Enterococcus faecalis and E. coli in a 92-year-old Male with Indwelling Catheter

For a 92-year-old male with an indwelling catheter and UTI caused by Enterococcus faecalis and E. coli, the optimal treatment is ampicillin/sulbactam with catheter replacement, followed by targeted therapy based on susceptibility results. 1, 2

Initial Assessment and Management

  • Obtain urine culture prior to initiating antimicrobial therapy due to the wide spectrum of potential infecting organisms and increased likelihood of antimicrobial resistance in catheterized patients 2
  • Replace the indwelling catheter if it has been in place for ≥2 weeks, as this improves clinical outcomes and decreases polymicrobial bacteriuria 2
  • Collect a new urine specimen from the freshly placed catheter before starting antibiotics to ensure accurate culture results 2

Empiric Antibiotic Selection

  • Ampicillin/sulbactam is recommended as first-line therapy for coverage of both E. faecalis and E. coli in this elderly patient with an indwelling catheter 1, 3
  • Consider renal function when dosing antibiotics, as elderly patients often have reduced kidney function 1
  • Avoid fluoroquinolones (ciprofloxacin, levofloxacin) despite their FDA approval for complicated UTIs with enterococci 4, as resistance rates are high (47% for ciprofloxacin in E. faecalis) 3

Targeted Therapy Based on Culture Results

For E. faecalis:

  • Ampicillin/amoxicillin if susceptible (drug of choice for enterococcal infections) 1
  • Fosfomycin 3g oral powder as a single dose if oral therapy is appropriate and the infection is limited to the lower urinary tract 1
  • Nitrofurantoin 100mg four times daily for uncomplicated lower UTI, but use with caution in elderly patients with reduced renal function 1

For E. coli:

  • Continue with ampicillin/sulbactam if susceptible 3
  • Adjust therapy based on susceptibility results, considering the patient's age and renal function 1

Duration of Treatment

  • For complicated UTI in this elderly patient with an indwelling catheter: 7-14 days of therapy is recommended 2, 1
  • Treatment may need to be extended if the patient does not have a prompt clinical response with defervescence by 72 hours 2

Special Considerations for Elderly Patients with Catheters

  • Elderly patients with long-term catheters have a greater risk for bacteremia and other urinary complications 5
  • Biofilms form on both internal and external catheter surfaces, protecting organisms from antimicrobials and host immune response 5
  • Male gender and advanced age are risk factors for resistant organisms, particularly in E. faecalis UTIs 6, 7

Monitoring and Follow-up

  • Monitor for clinical improvement within 72 hours of initiating therapy 2
  • If no improvement occurs, consider catheter replacement (if not already done) and reevaluation for possible complications 2
  • Obtain follow-up urine cultures if symptoms persist despite appropriate therapy 1

Common Pitfalls to Avoid

  • Treating asymptomatic bacteriuria in catheterized patients is not recommended as it leads to antimicrobial resistance without clinical benefit 2
  • Routine periodic changing of indwelling catheters to prevent CA-bacteriuria is not evidence-based 2
  • Prophylactic antimicrobials should not be administered routinely at the time of catheter placement, removal, or replacement 2
  • Using fluoroquinolones empirically is not recommended due to high resistance rates in enterococci 1, 3

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.